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INTRODUCTION 
 
 
 
 
INTRODUCTION 
 
 
 
          The Indian subcontinent is undergoing an epidemiological 
upheaval as non-communicable diseases are becoming major cause of 
mortality and morbidity. Already the Indian subcontinent contributes to 
16-18% of global mortality due to cardiovascular disease. By the year 
2020, India is projected to have the largest number of individual 
cardiovascular risk factors. The current data suggests that prevalence of 
metabolic syndrome is about 40% higher than 25% quoted for western 
population. 
 
        Rising incidence of diabetes mellitus, systemic hypertension and 
dyslipidemia, the well known risk factor for cardiovascular disease is the 
leading cause for increased incidence of cardiovascular diseases1. Till 
today, body mass index and waist circumference are the two popular 
parameters used to assess the cardiovascular risk factors. Though Asian 
people are not overtly obese, they are still at an increased risk of 
cardiovascular disease and this may be due to presence of visceral 
obesity, but the cut off value for waist circumference varies among sex, 
ethnics and countries. So we are still in need of simple, cheap and 
effective anthropometric parameter to assess cardiovascular risk of our 
population. In our study, use of Waist/Height ratio parameter was 
assessed for identifying cardiovascular risk and to compare with other 
studies.  
                                
          The average height of Asian is low, when compared to western 
countries. Height is an independent negative predictor of cardiovascular 
disease, so waist circumference, as a parameter of visceral obesity should 
be taken in context to height as waist/height ratio. 
 
         Waist/height ratio with cut-off >0.5 is the newer parameter under 
clinical trial expected to emerge in clinical practice in near future. In our 
study, effectiveness of waist/height ratio was studied in identifying 
cardio-metabolic risk factors. This parameter was also compared with 
well known other parameters like body mass index and waist 
circumference in our study. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF 
LITERATURE 
 
 
REVIEW OF LITERATURE 
 
Evolution of cardio-metabolic risk factors clustering as a 
‘syndrome’ 
 The propensity of clustering of metabolic and 
cardiovascular risk factors in the same individual has been 
recognized for many years. The first description of cardio-
metabolic risk factor clustering appeared in the medical 
literature in 1923,when Eskil Kylin (1889 – 1975), a Swedish 
physician, described a syndrome involving hypertension, 
hyperglycemia, and hyperuricemia. Sixty five years later in 
1998, Reaven described a cluster of risk factors for diabetes 
and CARDIO VASCULAR DISEASE. (hypertension, 
hyperglycemia, glucose intolerance, elevated triglycerides and 
low HIGH DENSITY LIPOPROTEIN level). He named it as 
syndrome X and introduced the concept of insulin resistance4. 
       In 1998 WHO proposed the term metabolic syndrome 
rather than insulin resistance syndrome, since insulin 
resistance alone could not explain all components of the 
syndrome. However use of the term ‘metabolic syndrome’ 
remained relatively uncommon until 2001 when the National 
cholesterol education program Adult treatment panel (NCEP 
ATP III) identified the metabolic syndrome as a risk factor for 
CARDIOVASCULAR DISEASE and as a target for lipid – 
modifying and other CARDIO VASCULAR DISEASE risk 
reduction therapies.  
Criteria proposed for clinical diagnosis of metabolic 
syndrome 
Clinical 
measure 
WHO (1998) ATP III (2001) 
Insulin 
resistance 
IGT, IFG or lowered 
insulin sensitivity plus 
any two of the following 
None, but any 3 of the 
following 5 features 
Body weight Men : WHR > 0.90 
Women: WHR > 0.85 
and / or BMI > 30kg/m2 
WC > 102 cm in men or 
> 88 cm in women 
Lipid  TG > 150 mg/dL and / or 
HIGH DENSITY 
LIPOPROTEIN  
< 35mg/dL in men  
or < 39 mg/dL in women 
TG > 150 mg/dL 
HIGH DENSITY 
LIPOPROTEIN 
<40mg/dL in men or 
<50mg/dL in women 
Blood pressure  >140/90 mmHg >130/85 mmHg 
Glucose IGT, IFG or T2DM >110 mg/dL (includes 
diabetes) 
Other  Microalbuminuria Other features of insulin 
resistance  
GENERALISED OBESITY 
 The majority of the patients with CORONARY ARTERY 
DISEASE are overweight and severity of the disease is more 
in them. Obesity markedly reduces the life span by about 22% 
(Kevin P et al). Obesity is associated with increased risk of 
hypertension, diabetes, dyslipidemia and CORONARY 
ARTERY DISEASE26.  
 
BMI (Body mass index) which is defined as the weight in 
kilogram divided by height in meter squares is now accepted 
as an important measure of obesity.  
 
Classification of overweight and obesity by body mass 
index (Kg/m2) 
 Underweight  < 18.5 
 Normal 18.5 – 24.9 
 Overweight  25 – 29.9 
 Obesity 
  Class I  - 30.0 – 34.9 
  Class II - 35.0 – 39.9 
  Class III - >40(Extreme obesity) 
                                                         (API Text Book) 
 The drawback of BMI is that, it does not convey 
information about the distribution of body fat. South Asians 
have increased abdominal visceral fat and greater insulin 
resistance at lower levels of BMI, which suggest that reliance 
on BMI alone may underestimate true risk in our population27. 
Now WHO has revised obesity cut off for Asians from BMI > 
30 to BMI > 25.  
 
Cut off points of BMI for Asian Indians (Hubbard et al) 
 Underweight  < 18.5 
 Normal range 18.5 – 22.9 
 Overweight > 23 
  At risk  -  23 – 24.9 
  Obese I - 25 – 29.9 
  Obese II - > 30 
 
Apple type and pear shaped obesity 
 On the basis of body fat distribution, obesity may be 
classified into android and gynoid types.  
 
 Android obesity is the collection of fat mostly in the 
abdomen (above the waist). It is also called central obesity 
and is associated with an increased risk of metabolic 
complications such as CORONARY ARTERY DISEASE, DM, 
HT and dyslipidemia. It is the most common acquired cause of 
insulin resistance. Also known as apple type body5.  
 
 Gynoid obesity (Pear shaped body) is the collection of 
fat on the hips and buttock (below the waist or gluteo-
femoral). This makes the person more prone to mechanical 
disorders such as varicose veins and disorders of the joint.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BMI AND WEIGHT CUT POINT FOR OVERWEIGHT 
AND OBESITY AT DIFFERENT HEIGHTS IN ASIAN 
INDIANS 
Adapted from NHLBI obesity Task Force, 199859 
diabetes.com.au/research.obesity.htm .Feb 2006. 
Optimum Overweight Obese 1 Obese 2 BMI 
20 23 25 30 
Height in 
Cm 
Weight in 
kg 
   
146 43 49 53 64 
149 44 51 56 67 
152 46 53 58 69 
155 48 55 60 72 
158 50 57 62 75 
161 52 60 65 78 
164 54 62 67 81 
167 56 64 70 84 
170 58 66 72 87 
173 60 69 75 90 
176 62 71 77 93 
179 64 74 80 96 
182 66 76 83 99 
185 68 79 86 103 
188 71 81 88 106 
191 73 84 91 109 
194 75 87 94 113 
197 78 89 97 116 
200 80 92 100 120 
MEASURE OF ABDOMINAL OBESITY:  
The abdominal or truncal obesity was measured by  only few 
anthropometric indices.  
They are  
1. Waist circumference 
2. Waist /Height ratio ( Newer parameter)  
As evidenced the abdominal obesity is a marker of insulin resistance. So 
anthropometrics used to measure abdominal obesity correlates with 
cardiovascular risk factors.  
 
WAIST CIRCUMFERENCE:  
 Till now the most popular and effective anthropometric parameter 
used to assess abdominal obesity and cardio metabolic risks is waist 
circumference. Waist circumference was measured at the mid level 
between lower costal margin and Iliac crest. The cut off proposed for 
waist circumference by ATP – III criteria is  
                                     Males> 102 cms 
                                     Females > 88 cm 
            But for Asians the waist circumference is low when compared to 
western population.  
 
 
In Asians, the cut off value used for waist circumference is  
                                      Males> 90 cms 
                                      Females > 80 cms. 
 
 In metabolic syndrome, waist circumference is the anthropometric 
parameter used to measure insulin resistance. In Asians the BMI is low 
when compared to western population but they are at increased risk of 
cardio vascular disease5. The pattern of obesity among Asians is 
abdominal obesity; Till now, waist circumference was the best parameter 
used in assessing conventional cardio vascular risk factors like, 
          1. Glucose intolerance  
          2. Hypertension  
   3. Dyslipidemia .  
 
DRAW BACKS OF WAIST CIRCUMFERENCE:  
1. There is no International standard cut off values for waist 
circumference.  
2. Different cut off used for various ethnic groups.  
3. Cut off values varies among both sexes.  
4. Height,an independent negative risk factor for cardiovascular 
disease is not taken into account.  
 
 In Asians, as per evidence the average height is lower when 
compared to western population. With same waist circumference the 
cardio vascular risk of a individual varies for different height. As height 
increases, the cardio vascular risk decrease2. So we are still in need of a 
better parameter to identify cardio vascular risks.  
 
WAIST / HEIGHT RATIO: (NEWER PARAMETER)  
 Waist / Height ratio was the  new parameter under study to identify 
cardio vascular risk factors. Few studies are done among Japanese 
population to assess the effectiveness of Waist / Height ratio in 
identifying cardio vascular risk factors. This study was published in the 
Journal of Preventive Medicine in July 2004. Fewer similar studies are 
conducted among Japanese population28.  
 
 The cut off used in the study for waist / height ratio is 0.5, above 
which it is abnormal. It means the waist circumference should be kept 
below half of the height of the individual. If the waist circumference is 
more than half of the height, the cardio vascular risk increases as per the 
study. In the study it was also found that waist / Height ratio was the 
superior parameter than BMI and waist circumference in identifying 
cardio vascular risk factors.  
 
ADVANTAGES OF NEWER PARAMETER OVER OLDER ONES:  
 In waist / height ratio, the cut off values are the same for all ethnic 
groups, both sexes and for all ages. So the standard cut off  > 0.5 was 
used in all population.  
 Height, an independent negative risk factor for cardio vascular 
disease is also taken into account; waist circumference is viewed in the 
context of height. So accurate assessment of cardio metabolic risk  can  
be  done  using  this  parameter. It also helps in  identifying the cardio 
vascular risk factors at an early stage compared to BMI and waist 
circumference. So it provides early options for therapeutic intervention to 
halt the progression of cardio vascular disease.  
 As per the results of the study done among Japanese population, 
this parameter has more sensitivity in identifying the cardio vascular risk 
factors. It also has close correlation with cluster of cardiovascular risk 
factors. In the study, it was found to be an effective and superior 
anthropometric parameter in identifying cardiovascular risk factors than 
BMI and waist circumference29. Indian and Western studies are not yet 
available on this parameter. But is expected to come in near future.  
 Since Waist / Height ratio is a cheaper and effective parameter as 
per study results conducted among Japanese population, this parameter 
may replace waist circumference in assessing cardio metabolic risks in 
near future.  
DIABETES MELLITUS 
 Both Diabetes and impaired glucose tolerance are associated with 
increased cardiovascular risk. A recent study in India showed a 
prevalence of diabetes and IGT as 12.1% and 15% respectively. 
  
         Diabetes is associated with central obesity, hypertension,  
atherogenic dyslipidemia and insulin resistance, all of which have been 
associated with high CAD risk. Diabetic dyslipidemia consists of  
elevated triglyceride, low HDL, and an increased proportion of small 
dense LDL6. 
 
HYPERTENSION 
         Hypertension is a strong risk factor for CAD. It accelerates the 
atherosclerotic process especially if Hyperlipidemia is also present.  
Recent data shows that even high normal levels (SBP 130-139mm of Hg 
and DBP 85-89 mm of Hg) are associated with doubling of CAD risk. 
Hypertension is closely related with salt intake, alcoholism and obesity7. 
 
INSULIN RESISTANCE AND VISCERAL OBESITY: 
     Metabolic syndrome is a collection of risk factors that together 
increase the risk of cardiovascular morbidity and mortality. The central 
factor in metabolic syndrome is proved to be Insulin resistance. 
 
      Insulin Resistance can be primary (genetic ) or secondary8. The 
central obesity; a quite essential feature of metabolic syndrome is 
strongly related to Insulin resistance and may contribute to its 
pathogenesis through an increase in visceral adipocytes30. 
 
INSULIN RESISTANCE AND TYPE 2 DM: 
Visceral adipoctyes play an important role in the development of Type 2 
Diabetes Mellitus9. 
         (1) Lipid accumulation in Liver and muscles, leads to Insulin 
insensitivity in these areas and may lead to Type 2 DM.  
          (2) Lipid accumulation in Islets may lead to apoptosis of β cells 
and Type 2 DM. 
 
INSULIN RESISTANCE AND SYSTEMIC HYPERTENSION: 
      Hyper Insulinemia in insulin resistance 10may lead on to 
hypertension in various ways like  
         (1)Sodium and Water retention, 
         (2) Anti-natriuretric effect, 
         (3)Sympathetic Overactivity, 
         (4)Smooth muscle proliferation , 
         (5)Vasoconstrictor effect. 
 
INSULIN RESISTANCE AND DYSLIPIDEMIA: 
      Insulin Resistance also contributes to dyslipidaemia by various 
mechanisms. Insulin resistance at the level of adipose tissue causes 
increase in release of free fatty acids which was taken up by liver and 
results in increased VLDL particle secretion. These raised levels of 
VLDL circulation then exchange their TGL content for cholesterol esters 
from HDL and LDL. This triglyceride rich LDL is hydrolysed by 
Lipoprotein Lipase leading to formation of small dense LDL. Then the 
triglyceride rich HDL is a good substrate for hepatic lipase and releases 
some APoA  from it, which is lost through kidneys leading to increased 
HDL clearance11.  
Thus Insulin resistance leads onto 
                 (1) Hypertriglyceridemia,  
                  (2)Low HDL levels , 
                  (3)Increased levels of small dense LDL. 
 
INSULIN RESISTANCE AND ATHEROSCLEROSIS: 
         Visceral adipocytes increases the risk of atherogenesis in various 
ways by causing glucose Intolerance, hypertension and dyslipidaemia 
which are the important risk factors for atherosclerosis. Apart from these 
effects, visceral adipocytes aggregates atherosclerosis by secretion of 
various adipo cytokines and hormones.             
The inflammatory substances produced by the visceral adipocytes 
are C-reactive protein, IL6, TNF-α, plasminogen activator inhibitor-1, 
resistin and adiponectin. Among these substances adiponectin plays a 
protective role against atherosclerosis. 
          Atherosclerosis is caused by low grade chronic inflammation, so 
these inflammatory adipocytokines play a dominant role in pathogenesis 
of atherosclerosis. 
                       Visceral adipocytes  
 
 
              Adipocytokines (Humoral factors)                                       
Diabetes Mellitus                                 
Hypertension 
Dyslipidemia 
                        Low grade chronic inflammation                                 
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                         Cardiovascular Disease 
                                     
HUMORAL FACTORS IN CENTRAL OBESITY AND INSULIN 
RESISTANCE 
 
 Adipocytes are now known to secrete a wide range of products, 
some of which may impair insulin action through endocrine effects on 
distant target tissues and / or paracrine actions on neighbouring cells12.  
 
 
LEPTIN 
 
          Circulating leptin concentrations are proportional to total body fat  
mass, making it an attractive  candidate as a mediator of 
insulin resistance in obesity . However, this notion remains 
controversial: 
       Some studies suggest that leptin interferes with  insulin 
action in the liver, whereas others report inhibition of hepatic 
gluconeogenesis. Leptin has also been  reported to inhibit 
insulin signalling in adipose tissue. Leptin has no obvious 
direct effect on  insulin action in skeletal muscle, but it may 
activate central sympathetic nervous system activity, and this 
could induce insulin resistance. Paradoxically, in a mouse 
model of lipoatrophic diabetes, it was found that Leptin can 
partially improve insulin action. Recently Leptin replacement 
has been shown to  reverse insulin resistance in human 
subjects with lipoatrophic diabetes and low circulating leptin 
levels. Leptin mRNA concentrations are lower  in visceral 
than subcutaneous fat, so it is possible that insulin-sensitizing 
effect is diminished in subjects with a high visceral fat mass. 
 
 
TUMOUR  NECROSIS  FACTOR 
This cytokine is produced in adipose tissue; its 
expression is increased in obesity, and early evidence 
suggested that it might interfere with insulin signaling 
directly, by inhibiting phosphorylation of the insulin receptor. 
Furthermore, TNF knockout mice are more insulin-sensitive 
than controls, and immunoneutralization with anti-TNF 
antibodies improves insulin sensitivity in rodents.  
In humans, circulating TNF levels  tend to correlate with 
adiposity and insulin sensitivity in some studies but the 
importance of circulating TNF as a mediator of obesity related 
insulin resistance has been questioned, because concentrations 
are low, immunoneutralization experiments do not affect 
insulin sensitivity and most circulating TNF is derived from 
sources other than a recent study indicated that insulin-
mediated glucose uptake was negatively correlated with TNF-
alpha secretion from human adipocytes. 
 
ADIPONECTIN 
Adiponectin (also known as Acrp30 and Adios) is a 
recently described adiposity product that intriguingly appears 
to ameliorate insulin resistance in both muscle and liver. It is 
a 244-residue cytokine-like protein with some structural 
homology to TNF. In rodents, its expression and secretion fall 
with increasing fat mass, and adiponectin replenishment 
improves insulin resistance in various models of genetic and 
diet-induced obesity. Treatment with insulin-sensitizing 
PPAR-gamma agonists  such as rosiglitazone increased 
adiponectin expression. Interestingly, treatment of 
lipoatrophic diabetes with adiponectin also improved insulin  
resistance and the effects were additive to those of leptin. It is 
therefore hypothesized that low levels of adiponectin might 
contribute to insulin  resistance in  obesity. The mechanism by 
which adiponectin might improve insulin resistance is yet to 
be clarified, but current evidence suggests that it increases fat 
oxidation in both muscle and liver tissue. In humans, 
adiponectin levels are also decreased in obesity, and rise with 
weight loss13. The adiponectin gene is localized to human 
chromosome 3q27, a locus that has been associated with 
susceptibility to type 2 diabetes and the metabolic syndrome 
in genetic studies. Further more, adiponectin accumulates in 
vessel walls and inhibits TNF-induced cell adhesion, and  thus 
also implicated in protection against endothelial dysfunction 
suggesting a wider role in the pathogenesis of the metabolic 
syndrome. 
 
 
RESISTIN 
Resistin (independently identified as Fizz3) is the 
product of an adipocyte-specific gene whose expression is 
down-regulated by the insulin-sensitizing thiazolidinediones. 
Subsequent work suggested that resistin was secreted by 
adipocytes, that dietary obese mice had high circulating 
resistin levels, and that administration of resistin  antibodies 
ameliorated insulin resistance in these mice14. Resistin was 
named for its putative role in mediating insulin resistance in 
obesity. 
 Subsequent reports have  some doubts over this hypothesis, as 
another PPAR gamma agonist, GW 1929, appears to up-regulate resistin 
gene expression; moreover, the human homologue of resistin is only 
expressed at very low  levels in adipose tissue, and does not appear to be 
regulated by PPAR gamma agonist. Clarification of its role and possible 
impact on insulin signaling is awaited. 
 
Peroxisome proliferator-activated receptor- gamma 
 
           This nuclear receptor is expressed principally in 
adipocytes and has been identified as the target for the 
thiazolidinedione class of insulin-sensitizing drugs. Dominant 
negative mutations are associated with severe insulin 
resistance. PPARG gene knockout models show increased 
insulin sensitivity, indicating  that this gene has complex roles 
in regulating insulin sensitivity; this is not surprising, given 
its numerous effects on the differentiation of adipocytes and 
other cell types. The PPARG gene is also expressed in skeletal 
muscle, although at a lower level than in adipose tissue. PPAR 
gamma expression has been reported to be higher in skeletal 
muscle in obese subjects, but its expression is not altered in 
subjects with type 2 diabetes, independently of obesity15.  
       Recently a common polymorphism (Pro 12Ala) in the 
PPARG been found to be associated with  increased insulin 
sensitivity in humans, although whether this protects against 
the development of diabetes in humans remains to be seen. 
 
Various cytokines and other factors, including PAI-1 and 
IL-6 also have been found to be produced in adipose tissue, 
and could play a role in insulin  resistance. For example  PAI-
1 production is stimulated  by insulin, and there is some 
evidence that increased levels may contribute to the 
prothrombotic state  and IL-6 has been associated with insulin 
resistance in Pima Indians. 
 
CORONARY ARTERY DISEASE 
 Coronary artery disease is the leading cause of death all 
over the world. CORONARY ARTERY DISEASE rate vary 10 
fold among populations. CORONARY ARTERY DISEASE 
rates among overseas Asian Indians world wide are 50% to 
400% higher than people of other ethnic origin irrespective of 
gender, religion and cast16.  
 India is now in the middle of a CORONARY ARTERY 
DISEASE epidemic with urban Indians having CORONARY 
ARTERY DISEASE rates which is 4 fold higher than 
Americans (Enas Enas et al).  
 
Cardinal features of CORONARY ARTERY DISEASE 
among Asian Indians:  
        (1)Asian Indians are prone to develop CORONARY 
ARTERY DISEASE at a younger age, often before the age of 
40 years in men.  
 
        (2)They are more likely to have an anterior location of 
infarction and are significantly younger at the time of firs 
hospitalisation for heart failure. 
           
         (3)CORONARY ARTERY DISEASE in Indians is 
known to be severe, extensive and malignant despite a lower 
age and a greater proportion of non smokers.  
 
 CORONARY ARTERY DISEASE mortality rates are 2 
fold higher in Asian Indian women of 45-64 years of age than 
in whites17.  
 
 
Prevalence of CORONARY ARTERY DISEASE in India:  
 In India the number of deaths due to CORONARY 
ARTERY DISEASE was 1.7 million in 1990 and 1.59 million 
in 2000. It is projected to be 2.03 million by 2010.  
 
 The prevalence of CORONARY ARTERY DISEASE in 
urban India is double the rate than in rural India. The rates 
appear to be higher in south India with Kerala having a 
prevalence of 13% in urban areas and 7% in rural areas. 
CORONARY ARTERY DISEASE prevalence in New Delhi is 
10% and in Chennai, it is 11% (2). These rates are similar to 
those among more affluent overseas Indians.  
 
 The excess burden of CORONARY ARTERY DISEASE 
in Asian Indians is due to a genetic susceptibility, mediated 
through elevated levels of lipoproteins which magnifies the 
adverse effects of lifestyle factors associated with 
urbanization, affluence and changes in diet. There is higher 
rate of abdominal adiposity among urban population, which 
results in significant dyslipidemia and insulin resistance and a 
3 fold increase in diabetes. A more aggressive approach to 
prevention and treatment of both conventional and emerging 
risk factors is warranted in Indians.  
 
Risk factors for CORONARY ARTERY DISEASE 
 Risk factors for CORONARY ARTERY DISEASE can be 
broadly divided into modifiable and nonmodifiable. The 
modifiable one can be again divided into lipid and nonlipid 
factors.  
 
Non modifiable risk factors 
1. Age: 
  Male > 45 years 
  Female > 55 years 
2. Family history of premature CORONARY ARTERY 
DISEASE –  
  Male first degree relative < 55 years 
  Female first degree relative < 65 years 
3. Male Sex:  
 
Modifiable – non lipid risk factors:  
1. Hypertension 
2. Diabetes 
3. Smoking 
4. Life style risk factors:  
 Obesity – BMI > 30 kg/m2 
 Physical inactivity 
 Atherogenic diet 
 
Modifiable – Lipid risk factors:  
1. Total cholesterol > 200 mg/dL 
2. Trigylceride        > 150 mg/dL 
3. HIGH DENSITY LIPOPROTEIN  < 40 mg/dL 
4. LOW DENSITY LIPOPROTEIN   > 100 mg/dL 
 
Emerging risk factors 
1. Impaired fasting glucose  
2. Homocysteine > 15 µmol/L 
3. Subclinical atherogenesis 
4. Prothrombotic factors 
5. Proinflammatory factors                                  
                                                JAMA 285, 2486 ; 2001 
 
 
 
Coronary risk factors for Asian Indians 
Fixed 
      Male age > 25 years 
      Female age > 45 years 
      Family history of premature CORONARY ARTERY 
DISEASE < 55years 
Modifiable non lipid 
 Hypertension 
 Cigarette smoking / Tobacco Abuse 
 DM / Insulin resistance syndrome 
 Apple obesity or BMI > 22 
 Homocysteine > 10 µ mol /L  
 High PAI – 1 
 
Modifiable lipid 
 TC > 150 mg / dL 
 TGL  > 150 mg / dL 
 LOW DENSITY LIPOPROTEIN > 100 mg / dL 
 Apo b > 100 mg /dL 
 HIGH DENSITY LIPOPROTEIN < 40 mg / dL in male  
                                                      < 50 mg / dL in females 
 
Modifiable lipoprotein ratio 
1. LOW DENSITY LIPOPROTEIN / HIGH DENSITY 
LIPOPROTEIN > 3.5 
2. TC / HIGH DENSITY LIPOPROTEIN > 4.5 
3. Apo a / Apo b < 1.2 
4. Lipid Tetrad = Lp(a) x TG x LOW DENSITY 
LIPOPROTEIN / HIGH DENSITY LIPOPROTEIN > 
20000 mg/dL 
                   (API text book of medicine – 7th edition p – 433).  
 
 CORONARY ARTERY DISEASE risk factors can also be 
classified as conventional and emerging risk factors. 
Compared to other ethnic groups, Indians have a lower 
prevalence of Hypertension, hypercholesterolemia, obesity and 
smoking, but a higher prevalence of high triglycerides, low 
level of HIGH DENSITY LIPOPROTEIN, glucose intolerance 
and central obesity. Although the conventional risk factors do 
not fully explain the excess burden of CORONARY ARTERY 
DISEASE, these risk factors appears to be doubly important 
and remains the principal target for prevention and treatment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIMS AND OBJECTIVES 
 
 
 
 
 
AIM OF THE STUDY 
 
1. To assess the effectiveness of the newer anthropometric index, 
Waist/Height ratio in identifying Cardiovascular risk factors. 
 
2. To compare the effectiveness of various anthropometric indices 
Body mass index, Waist Circumference and Waist/Height ratio 
in identifying Cardiovascular risk factors. 
 
3. To prove the superiority of Waist/Height ratio over body mass 
index and waist Circumference in identifying Cardiovascular 
risk factors. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND 
METHODS 
 
 
 
 
MATERIALS AND METHODS 
 
Selection of Subjects: 
     Among patients attending medical OP department in government rajaji 
hospital for various illness, 135 patients were included in our study  
                       Males  : 114   
                       Females : 21  
 
Period of the Study: 
     Patients were taken up during the period from January 2008 to 
October 2008. 
 
Age Group: 
     Patients were selected between the age group of 20-75 Years, both 
males and females. 
 
Exclusion Criteria: 
     135 patients were selected after excluding some patients because they 
produced falsely elevated anthropometric parameter, waist circumference 
and weight due to ascites and volume overload. 
 
They were 
          Chronic renal failure 
          Cirrhosis of liver 
          Congestive cardiac failure 
          Nephrotic syndrome 
          Hypo thyroidism 
          Ascites of any cause. 
 
History: 
      Careful history taking was first taken in these patients regarding 
pre existing diabetes mellitus, systemic hypertension and dyslipidemia 
and about the treatment for these illnesses. 
 
Anthropometry: 
    In all these patients the following anthropometric measurements are 
done 
                         (1)Height, 
                         (2)Weight, 
                         (3)Waist Circumference. 
 
 
 
Height: 
      Height was taken by asking the patient to stand erect against the 
wall and vertical height was measured in centimeters. 
 
Weight: 
     Weight was measured in kilograms using a weighing machine. 
 
Waist Circumference: 
     Waist circumference was taken using an inch tape at the midlevel 
between lower costal margin and Iliac crest. 
 
From these anthropometric measures, body mass index and 
Waist/Height ratio  were calculated. 
 
Body mass Index: 
     Calculated by the formula 
                        Weight in Kgs   
                        [ Height in cms]2 
  
Weight/Height ratio: 
                         Weight in Kgs  
                          Height in cms. 
Blood pressure recording: 
      BP was taken 3 times over a period of 1 week to confirm Systemic 
Hypertension. 
 
Investigations: 
     The following Investigations are done after a overnight fasting for 
>8 hours  
                            (1)Fasting plasma Glucose, 
                            (2)Serum Total Cholesterol, 
                            (3)HDL, 
                            (4)Triglyceride. 
The information collected regarding all the selected cases were 
recorded in a master chart. Data analysis was done with the help of 
Computer using Epidemiological information package (EPI 2002). 
Using this software, frequencies, percentages, means, standard 
deviations, chi -square and ‘P’ values were calculated. Kruskal wallis Chi 
– square test was used to test the significance of the  difference between 
quantitative variables and test for qualitative Variables. A ‘P’ value less 
than 0.05 is taken to denote  significant relationship. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS  
 
 
 
 
RESULTS AND ANALYSIS 
Profile of the study: 
     In our study ,135 patients was selected randomly. The cut off 
values of anthropometric indices which was taken as abnormal are 
                            Body mass index > 25kg/m2 
                              Waist Circumference   Males > 90cms 
                                                                    Females> 85cms 
                              Waist/Height ratio > 0.5 
 The cut off values for metabolic risk factors above which was taken as 
abnormal are               
                               Fasting plasma Glucose ≥ 110mg/dl 
                              Systemic Hypertension ≥ Sitting BP ≥ 140/90 mm Hg 
                              Total Cholesterol ≥ 220mg/dl 
                               HDL ≥ 40mg/dl 
                               Serum Triglycerides ≥ 150mg/dl 
          The cut-off values used in this study for cardiovascular risk factors 
was the same used in WHO criteria for metabolic syndrome but the waist 
circumference cut off  value in our study was taken from the values for 
Asian population. The cut-off value for waist/height ratio was taken as > 
0.5 because this was the cut-off used in a previous similar study done 
among Japanese population. 
 
(A)Characteristics of Cases studied 
                                    Table 1: Age Distribution 
     The following table categorises patients in our study according to the 
age.      
Cases    Age group 
(in years) No % 
Less than 30 4 3.0 
30-39 17 12.6 
40-49 35 25.9 
50-59 44 32.6 
60-69 29 21.5 
70 & above 6 4.4 
Total 135 100 
Mean 
S.D. 
50.7 years 
11.6 years 
   
          In our study patients were between the age group 20-75. The mean 
age group in our study was 50.7+ 11.6 years. This mean age of patients in 
our study is the ideal age for our study, because the cardiometabolic risk 
factors appears to be high in this age group (Figure 1). 
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Table 2: Sex distribution 
         The following table shows sex distribution of patients in our study. 
 
Cases 
Sex 
No % 
Males 108 80 
Females 27 20 
 
 In our study group ,80% of patients were males. Females were less 
in our study because acceptance to take part in the study was less among 
female sex. The reason for which most of the females were not willing to 
take part in the study was not known (Figure 2). 
 
Table 3: Weight & Height 
The following table shows the mean weight and mean height of patients 
in our study. 
Cases 
Parameter 
Mean S.D. 
Weight (kgs) 58.4 10.4 
Height (cms) 159.3 12.3 
 
 
 
 
 
 
Figure 2 
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B. Anthropometric Indices: 
 
Table 4: BMI of patients in our study. 
 
The following table shows the percentage of patients with 
abnormal BMI. 
 
Cases 
Parameter 
Mean S.D. 
Weight kgs 58.4 10.4 
Height cms 159.3 12.3 
 
           The cut off value of body mass index above which it was taken as 
abnormal in our study was > 25. The mean BMI in our study group was 
23.7. It was clearly made out from the table that nearly 70% of the study 
group has normal BMI. This is similar to the pattern seen among Asians, 
where the BMI was less but cardiometabolic risks are high. 
 
 
 
 
 
Table 5: Waist Circumference 
       
      This table shows the number of patients with abnormal waist 
circumference in our study group.  
 
Cases Waist circumference 
(cms) No % 
Normal  [M< 90 & F < 85] 97 71.9 
Abnormal [M> 90 & F > 85] 38 28.1 
Mean 
S.D. 
86.1 cms 
24.6 cms 
 
    The mean waist circumference among the study group was 86 cms. 
Waist circumference was the best anthropometric index used in assessing 
cardiovascular risk factors in Asians as it measures truncal obesity and 
there by insulin resistance. In our patients, as in the general pattern for 
Asians, waist circumference was high inspite of having low BMI. 
 
 
 
 
 
Table 6 : Waist/Height Ratio: 
      The following table shows the percentage of patients in our study 
group with abnormal Waist/Height ratio. 
 
Cases Waist/Height  
ratio No % 
Normal ( < 0.5) 66 48.9 
Abnormal ( > 0.5) 69 51.1 
Mean 
S.D. 
0.62 
0.43 
 
It was found that nearly > 50% of patients in our study had higher 
Waist/Height ratio, but the BMI and waist circumference in these patients 
are low.  
Height is an independent negative predictor of cardiovascular 
disease. The average height of the Asian was low when compared to 
western population. The waist circumference is also low among our 
population. But the cardiometabolic risk was high. So waist 
circumference /height ratio was taken and its significance was assessed. 
 
 
 
C. Cardiac Risk Factors 
 
Table 7: Fasting Blood Sugar 
The following table shows percentage of patients with abnormal 
fasting plasma glucose i.e ≥ 110 mg/dl. 
Cases 
Fasting Blood Sugar 
No % 
Normal ( < 110 mg/dl) 109 80.7 
At Risk ( > 110 mg/dl) 26 19.3 
Mean 
S.D. 
98 
37.1 
         
The mean fasting plasma glucose among the study group was 98 
mg/dl. Fasting plasma glucose was the most widely accepted tool in the 
diagnosis of diabetes as recommended by the American diabetes 
Association. It was also easy and convenient for the patient, not waiting 
for two hours after breakfast as in postprandial blood glucose. But the 
major advantage with post prandial blood glucose was it was the first to 
become abnormal in early stage of diabetes. The cut-off value for fasting 
plasma glucose in our study was ≥ 110 mg/dl, because this was the cut off 
used in WHO criteria for metabolic syndrome. 
 
         
The following table shows the percentage of patients with past 
history of any of the cardiovascular risk factors like Type 2 DM, systemic 
hypertension and dyslipidemia. 
 
Table 8:  Patients Known past history  of Type 2 DM, Systemic 
Hypertension or Dyslipidemia 
 
Cases 
Known past history 
No % 
Yes 44 32.6 
No 91 67.4 
 
           This history was taken because patients fasting, BP, Lipid levels 
may be normal during the study due to treatment. In our study, only 32.6 
% of patients had past history of either diabetes, hypertension or  
dyslipidemia.  67.4 % had no above mentioned risk factors. 
 
 
                        
 
 
The following table shows percentage of patients in our study 
group with abnormal blood pressure . 
 
Table 9: Blood Pressure Pattern in our patients 
     . 
Cases 
Blood Pressure (mm Hg) 
No % 
Normal ( <  140/90) 82 61.2 
At Risk ( > 140/90) 53 38.8 
Systolic B.P. 
Mean 
S.D. 
Diastolic B.P. 
Mean 
S.D. 
 
132.9 
21.4 
 
83.8 
11.1 
 
  The cut off for abnormal BP in our study was ≥ 140/90 mm Hg 
because this was the cut off used in WHO criteria JNC 7 guidelines for 
diagnosis of systemic hypertension. In our study 38.8 % of patients had 
systemic hypertension. 
 
 
 
The following table shows the percentage of patients with 
abnormal total cholesterol in our study group. 
 
Table 10: Total Cholesterol 
 
 
 
Cases 
Total Cholesterol 
No % 
Normal ( <  220 mg/ dl) 107 79.3 
At Risk ( > 220 mg/ dl) 28 20.7 
Mean 
S.D. 
179.7 mg/dl 
50.1 mg/dl 
 
        The cut off value above which total cholesterol was considered 
abnormal in our study was ≥ 220 mg/dl. As per evidence, the pattern of 
dyslipidemia in asians shows that the total cholesterol levels are usually 
normal. In our study only 20% of patients had abnormal total cholesterol 
levels. So  our study reflects the same pattern as seen in asians. 
 
 
 
Table 11: TGL 
 
The following table shows percentage of patients with abnormal 
triglyceride levels among the study group. 
Cases 
TGL 
No % 
Normal ( <  150 mg/ dl) 74 54.8 
At Risk ( > 150 mg/ dl) 61 45.2 
Mean 
S.D. 
156 mg/dl 
63.3 mg/dl 
 
The mean TGL level among the study group was 156 + 63.3 mg/dl. 
Table 12: HDL 
 
The following table shows percentage of patients with abnormal 
HDL levels among our study group. 
Cases 
HDL 
No % 
Normal ( > 40 mg/ dl) 87 64.4 
At Risk ( < 40 mg/ dl) 48 35.6 
Mean 
S.D. 
40.5 mg/dl 
7.8 mg/dl 
 
The pattern of lipid among asian population was high triglyceride 
and low HDL levels. The total cholesterol and LDL levels are not that 
much high when compared to western population17. 
 
 
      The following table summarises the previous tabulations, shows % 
of patients with abnormal fasting plasma glucose, BP etc. 
 
Table 13: Abstract of Cardiac Risk Factors 
 
 
Cases 
Risk Factor 
No % 
1. Abnormal Blood Sugar (F) ( > 110 mg/dl) 26 19.3 
2. Past known history ( taking treatment) 44 32.6 
3. Blood Pressure ( > 140/90 mm Hg) 52 38.8 
4.Total Cholesterol ( > 220 mg/dl) 28 20.7 
5. TGL ( > 150 mg/dl) 61 45.2 
6. HDL ( < 40 mg/dl) 48 35.6 
7. Any one of the above factors present 114 84.4 
 
  Finally it shows the % of patients with any of the above cardiac 
risk factors among our study group( Figure 3). Nearly 85% of patients in 
our study group had at least one of the above cardiovascular risk factors. 
Only 34.6 % of patients had previous history of risk factors. Our study 
was also useful in detecting risk factors in rest of the patients. 
 
 
 
 
Figure 3 
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D. Relationship Between Profile of Cases and Cardiac Risk Factors 
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      The following table shows the Co-relation between the patient age 
and cardiovascular risk factors among our study group. 
 
 
Table 14: Age and Cardiac risk factor 
 
Age in years  
Cardiac risk Mean S.D. 
Present (114) 51.5 years 10.8 years 
Absent (21) 46.8 years 14.8 years 
‘p’ 0.0569 
Not Significant 
 
It was found that there is no statistically significant association was 
found between the age and cardiac risk factors. P value = 0.0569. 
 
 
 
 
 
 
The following table delineates the relationship between sex and 
cardiovasuclar risk factors. 
 
 
Table 15: Sex and Cardiac risk factor 
 
Sex 
Males Females Sex 
No % No % 
Present (114) 87 76.3 27 23.7 
Absent (21) 21 100 - - 
‘P’ 0.0059 
Significant 
 
         It was found that  the % of females with cardiovascular risk factors 
was found to be more in our study. The association between sex and 
cardiovascular risk factors was found to be statistically significant  
( P value  0.0059)( Figure 4). 
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The following table shows relationship between waist 
circumference and cardiovascular risk factors among our study group. 
 
Table 16: Waist circumference and Cardiac risk factor 
 
 
 
Waist circumference 
Normal Abnormal 
 
Cardiac risk 
No. % No. % 
 
Mean 
 
S.D. 
Present (114) 78 68.4 36 31.6 87.4 24.5 
Absent (21) 19 90.5 2 9.5 79 24.5 
‘p’ 0.0082 
Significant 
 
         The percentage of patients in our study group with abnormal waist 
circumference associated with any one of the cardiovascular risk factors 
was 31.6% (Figure 5).The association between them was statistically 
significant ( P value  0.0082). 
 
 
 
 
 
 
 
 
Figure 5 
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The following table shows co-relation of BMI with cardiovascular 
risk factors among our study group. 
 
Table 17: BMI and Cardiac risk factor 
 
 
BMI 
Normal Abnormal 
 
Cardiac risk 
No. % No. % 
 
Mean 
 
S.D. 
Present (114) 76 66.7 38 33.3 24.18 8.68 
Absent (21) 19 90.5 2 9.5 20.89 3.09 
‘p’ 0.0336 
Significant 
 
         
        It was found that nearly 33.3% of patients with abnormal BMI had 
any one of the cardiovascular risk factors( Figure 6). The association 
between BMI and cardiovascular risk factors also statistically significant. 
(P value  0.0336). 
 
 
 
 
  
 
 
Figure 6 
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 The following table shows correlation between Waist / Height  
ratio and the Cardiovascular risk factors among our study group. 
 
Table 18 :  Waist / Height ratio and Cardiac risk factor 
 
      
Waist / Height ratio 
Normal Abnormal Cardiac risk 
No. % No. % 
Mean S.D. 
Present (114) 51 44.7 63 55.3 0.56 0.21 
Absent (21) 15 71.4 6 28.6 0.49 0.14 
‘p’ 0.007 
Significant 
 
          It was found that  55.3% of the patients among our study group 
with abnormal waist/height ratio had any of the cardiovascular risk 
factors(Figure 7). 
The association between waist/height ratio and cardiovascular risk 
factors was found to be statistically significant ( P value 0.007). This was 
the prime aim of our study.  
 
 
  
 
Figure 7 
 
CO-RELATION BETWEEN WAIST/HEIGHT RATIO &  
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The following table compares the efficacy of the anthropometric 
indices in identifying the cardiovascular risk factors and also compares 
their statistical significance. 
Table 19: Efficacy of various parameters in predicting cardiac risk 
  
Cardiac risk (114 cases) 
Present Absent Parameter 
No. % No. % 
a) Abnormal Waist 36 31.6 78 68.4 
b) Abnormal BMI 38 33.3 76 66.7 
c) Abnormal Waist/Height Ratio 63 55.3 51 44.7 
‘p’ values between ‘a’ & ‘c’ 0.0005 
Significant 
‘p’ values between ‘b’ & ‘c’ 0.0014 
Significant 
‘p’ values between ‘a’ & ‘b’ 0.8875 
Not Significant 
     
By comparison it was found that among our study group, 
waist/height ratio was found to be more effective in identifying 
cardiovascular risk factors than other  indices like BMI and waist 
circumference. Nearly 55.3% of patients with abnormal waist/height ratio 
had  one or more of the cardiovascular risk factors(Figure 8).  
              
                 In our study the association between waist/height ratio and 
cardiovascular risk factors was found to be statistically significant. So the 
primary end point obtained from statistical analysis in our study was 
weight/ Height ratio was the more effective anthropometric index used in 
identifying cardiometabolic risk factors when compared to BMI and waist 
circumference. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 
PERCENTAGE OF PATIENTS IN OUR STUDY WITH  
CARDIAC RISK FACTORS 
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DISCUSSION 
 
 
 
 
 
DISCUSSION 
Epidemiology: 
All of the 135 patients taken for our study belong to low 
socioeconomic status group. These 135 patients were not  representative 
of  general population. Regarding their occupation most of them are cooly 
workers  with high physical activity. In our study the cardio metabolic 
risk and use of anthropometric measures are studied in this population. 
Previously it was thought that  diabetes mellitus, systemic 
hypertension, coronary artery disease and dyslipidemia were urban 
diseases. But today it is not so. The  prevalence and incidence  of these 
cardio metabolic diseases  is  high in India and is increasing even though 
>60% of Indians belong to low social economic group and living in rural 
areas. 
Among 135 patients taken in our study, 114 are males and 21 are 
females. Number of female patients taken in our study was low because 
many  female patients where not willing to take part in our study. More 
female patients should be studied to assess the anthropometric parameter 
usage in identifying cardio metabolic risk factors. 
 
 
The drawbacks in our study regarding case selection are 
1) Limited number of patients 
2) Female patients are less in number 
3) All Patients belong to low socioeconomic groups living in rural 
areas and so not representing the general population. 
 
Cardiovascular risk factors: 
      The cardiovascular risk factors taken in our study are  
a) Fasting plasma glucose 
b) Blood pressure 
c) Serum total cholesterol 
d) Serum triglycerides 
e) Serum HDL 
 
Fasting Plasma Glucose: 
           In our study fasting plasma glucose was taken after 8 hours fasting. 
The cut off values for fasting plasma glucose used in our study is  110 
mg/dl  above which it is considered abnormal .This cut off value is taken 
because this is the cut off value used in WHO criteria for metabolic 
syndrome and this is the same cut off used in the reference study done 
among Japanese people. The advantage of the fasting glucose is its 
reliability, convenience to the patients  and the values are  not altered by 
patient factors. The drawback of fasting plasma glucose is  that it may be 
normal in early stages of diabetes19.In such situations, post prandial 
plasma glucose is the ideal test. 
 
Blood Pressure: 
      In our study, BP is taken 3 times over a period of 1 week. The cut 
off values for BP is ≥ 140/90 mm Hg in our study. This same cut off is 
used in WHO criteria for metabolic syndrome and JNC 7 guidelines for 
diagnosis of systemic hypertension. systemic hypertension is considered 
an important cardiovascular risk factor. 
 
Dyslipidemia: 
      In our study fasting serum total cholesterol, triglyceride and HDL 
levels are taken. In asians the pattern of lipids is high triglycerides, with 
low HDL levels. In our study ,the mean total cholesterol is 180 mg/dl, 
mean triglyceride levels is 156 mg/dl and mean HDL levels is 40.5 mg/dl. 
Our study also reflects the same pattern of lipids among asians (3) . Shiun 
Dong Hsieh et al.2005 (1) also found the same pattern of dyslipidemia in 
his study group. 
 
 
 
Anthropometry: 
       The anthropometric indices taken in our study are 
a) BMI 
b) Waist circumference 
c) Weight height ratio 
 
Body Mass Index: 
      Generally asians have low BMI when compared to western 
population.  But  inspite of having low BMI in asians, the  risk of cardio 
metabolic diseases are high. In our study also, the mean BMI was 23.5 on 
the lower level.  
 
The  mean   BMI of patients  in the study conducted by Shiun 
Dong Hsieh et al.2005 (1) on Japanese population  also showed a 
similarly low value. 
 
Body mass index does not reflect the total fat mass, and also the fat 
distribution. It is found out that truncal obesity (both the subcutaneous 
and visceral fat)  are responsible for insulin resistance. Insulin resistance 
is the key factor in cardio metabolic diseases as shown in many studies20. 
BMI is not a good parameter to assess truncal obesity and insulin 
resistance.  
 
       In asians the incidence of visceral obesity is high, but the BMI is 
low. In our study the correlation of BMI with cardio metabolic risk 
factors is only 33.3%, but their association is statistically significant ( P 
value 0.0336). So according to our results, BMI was found to be less 
effective in identifying cardiovascular risk factors. Shiun Dong Hsieh et 
al.2005 (1)  in their study done among Japanese population also had the 
same results regarding BMI. 
 
      The BMI cut off used in our study is >25 kg/m2 standard value for 
all population. But a lower cut off for BMI may be required in identifying 
cardiovascular risks in Asians. 
 
Waist Circumference: 
 Waist circumference taken in our study is measured at the level of 
mid point between lower costal margin and iliac crest. Till now it is used 
as a better anthropometric index used in assessing truncal obesity. 
The major pit falls of waist circumference are 
1) There is no international standard value for all population. It 
varies among various ethnic groups. 
2) Different cut off values used for both sex. 
3) Height, a negative independent risk factor for cardiovascular 
disease is not taken into account. Cardiovascular Risk 
associated with  high waist circumference varies with height in 
the same individual. 
The cut off values taken for waist circumference in our study was 
males > 90cms and females > 85cms  as per asian standards. So the cut 
off values for  waist circumference taken in our study correlates with our 
Indian standards. 
In our study nearly 31.6% of patients with abnormal waist 
circumference has cardiovascular risks. This association is low , but it 
was found to be statistically significant in our study ( P values 0.0082) as 
found in the study conducted by Shiun Dong Hsieh et al.2005 (1). 
 
Waist/Height ratio:  
Still now effective anthropometric parameter to assess truncal 
obesity and insulin resistance with standard cut off values for all sex and 
ethnic group is not available21. So the prime aim of our study is to search 
for a new effective, standard and cheap anthropometric index ( i.e 
Waist/Height ratio) in identifying cardio metabolic risk factors. 
Waist/Height ratio is the newer parameter taken in our study, its 
effectiveness is studied and compared with other parameters like BMI 
and waist circumference. The reference for this study was taken from the 
Journal of preventive medicine published in July 2005( Shiun Dong 
Hsieh et al.2005 (1)). This  study was done in Japanese population with 
4,668 men and 1,853 women. The cut off for Waist/Height ratio used in 
the study was > 0.5 which was also the same cut off used in our study. It 
means that if waist circumference is more than half of the vertical height, 
the individual is at risk of cardiovascular disease22.  
      In our study nearly 55.3% of patients with abnormal Waist/Height 
ratio had cardiovascular risk. The association between Waist/Height ratio 
and cardiovascular risk factors was also found to be statistically much 
significant, the P value was 0.0005. But by comparison only 33.3% and 
31.6% of patients with abnormal BMI and waist circumference had 
cardiovascular risk. 
      In the large reference study among Japanese population (Shiun 
Dong Hsieh et al.2005 (1)) it was found that Waist/Height ratio was the 
superior parameter to evaluate clustering of coronary risk factors than 
BMI and waist circumference. In our study also Waist/Height ratio is the 
superior parameter. No Indian studies are yet available on Waist/Height 
ratio. Our study may act as a preliminary study among Indian population. 
 
 
 
 
 
Advantages of Weight/Height ratio found as per our study. 
 
1) Standard cut off values for both sexes and all ethnic groups and 
different ages. 
2) Height , an independent negative risk factor for cardiovascular 
disease is also  taken into account. Moreover, waist 
circumference should be viewed in context with height because 
individuals with same waist circumference with varying height 
have different cardiovascular risks. 
3) More accurate tracking of fat distribution and accumulation by 
age. 
4) Close correlation with cardio metabolic risk factors. 
5) More comprehensive identification of overweight individuals 
and those of normal weight and BMI facing higher 
cardiovascular risks. 
6) Higher sensitivity and more balanced sensitivity and specificity 
for an index of Waist/Height ratio > 0.5 for identifying higher 
risk people. 
7) Greater simplicity. 
 
 
      Waist circumference is a popular anthropometric index for 
measurement of central fat distribution and weight management (WHO 
2000). However the suggested boundary value of waist circumference 
varies by gender and ethnicity23. Height in contrast is an important factor 
that should be considered before adopting such an index because height 
may confound observation of fat accumulation and/or distribution. If we 
intend to use a single index of waist circumferences for health 
educational purposes, then shouldn’t we clarify that people with similar 
waist circumferences share similar health risks irrespective of height?. 
The data and the inverse correlation seen between height and age in cross 
sectional studies in asians were attributed  to the fact the early nutritional 
environment of asians differ dramatically in different generations. On the 
other hand, Weight/Height values showed fewer sex based differences 
than those for waist circumference and even BMI at various age intervals. 
Thus, using a height adjustment for waist circumference might better 
reflect the relative fat distribution of asian Individuals. There are also a 
number of reports concerning the inverse and independent effect of the 
risk factors of cardiovascular disease. Infact the use of a single index of 
waist circumference for all individuals may lead to an over estimation of 
risk in tall people and under estimation of risk in short people24. 
 
In our study by comparison it was found that Waist / Height values 
is the superior and effective parameter in identifying cardio metabolic 
risk in both sexes. Till now only few studies are available on this. No 
Indian study is yet available, so our study provides a preliminary 
evidence that Waist/Height values may be  a superior and effective 
anthropometric index25. 
 
According to our study “Keep your Waist Circumference 
below half of your Height”  may be a simple and effective public 
health message for the prevention of metabolic syndrome. 
 
More Indian studies done among larger and different populations 
are required to confirm this observation. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION  
 
 
 
CONCLUSION 
 
As per our study  
 
a) Waist/Height ratio with cut off  > 0.5 is found to be an 
effective, newer and cheaper anthropometric index in 
identifying cardiovascular disease. 
 
b) Waist/Height ratio with cut off  > 0.5 is a effective parameter in 
all ages and both sexes among Indians. 
 
c) Waist/Height ratio with cutoff > 0.5 is the superior parameter in 
identifying cardiovascular disease than BMI and waist 
circumference. 
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APPENDIX I – PROFORMA 
USE OF WAIST HEIGHT RATIO IN IDENTIFYING 
CARDIOVASCULAR RISK FACTORS 
Name:    
Age 
Sex 
Past History: DM  /  HTN  /  Dyslipidemia 
 
Anthropometry 
                         Height  
                          Weight 
                          Waist Circumference 
                          BMI 
                         Waist Height Ratio 
 
GENERAL EXAMINATION 
                             BP 
 INVESTIGATIONS 
                            Fasting Plasma Glucose 
                            Fasting  Serum Total Cholesterol 
                            Fasting  Serum  HDL 
                            Fasting  Serum  Triglcerides 
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1 Nagaraj, 52/M 55 164.5 20.33 75 0.46 92 130 80 177 103 34 2 2 
2 Narayanan, 60/M   55.5 164 20.64 86 0.52 86 140 90 163 99 39.7 2 2 
3 Manickam, 60/M 54 159.5 21.23 79 0.50 110 150 90 190 302 39.7 2 2 
4 Arjunan,  60/M 68 168 24.09 97 0.58 86 120 80 210 194 40.8 2 2 
5 Meenakshisundaram 50/M 65 169.5 22.62 90 0.53 86 130 80 161 123 29.1 2 2 
6 Bose 60/M 70 168 24.80 90 0.54 80 120 80 307 140 59 2 2 
7 Lakshmi 55/F 75 150 33.33 110 0.73 89 130 90 188 175 45.1 2 2 
8 Panchavarnam 46/F 70 154 29.52 92 0.60 90 140 90 214 175 35 1 2 
9 Panchachalam 60/M 55 157.5 22.17 88 0.56 85 130 100 160 122 34.7 1 2 
10 Suseela 60/F 65 154.5 27.23 90 0.58 65 130 90 223 345 38.9 2 2 
11 Lakshmi 60/F 55 141 27.66 86 0.61 66 130 90 187 159 47.6 2 2 
12 Nagoor 40/M 81 168 28.70 100 0.60 92 180 90 178 204 31.8 2 2 
13 Gurusamy 55/M 54 163 20.32 82 0.50 85 130 80 181 80 48.2 2 2 
14 Packialakshmi 58/F 64 154 26.99 84 0.55 80 130 90 192 104 70.9 2 2 
15 Arunagiri /M 65 172 21.97 92 0.53 82 150 90 233 126 40.6 1 2 
16 Jeyalakshmi 47/M 60 165 22.04 79 0.48 89 160 90 113 100 25.5 2 2 
17 Lakshmi 55/F 49 174 16.18 66 0.38 72 170 100 79 102 25.5 2 2 
18 Boopathy 60/M 49 164 18.22 74 0.45 82 138 90 247 153 50.4 2 2 
19 Thangamani 43/M 54 160 21.09 74 0.46 65 140 90 169 122 31.3 2 2 
20 Rajathi 51/F 56 145 26.63 88 0.61 70 140 90 181 122 48.2 1 2 
21 Challammal 62/F 52 144 25.08 72 0.50 65 150 100 218 143 49 1 2 
22 Subedha 63/F 63 154 26.56 84 0.55 92 130 80 214 196 64.1 2 2 
23 Manickam 85/M 69 159 27.29 82 0.52 100 160 100 219 193 56.3 2 2 
24 Vijaya 54/F 60 153 25.63 87 0.57 89 140 100 187 130 42.3 2 2 
25 Manimegalai 60/F 55 147 25.45 80 0.54 86 150 110 279 379 54.7 1 2 
26 Thirupathi 55/M 54 145 25.68 80 0.55 91 200 110 169 181 39.4 2 2 
27 Mumtaj 50/F 66 147 30.54 87 0.59 130 130 90 273 355 44.4 2 2 
28 Chellathai 60/F 55 149 24.77 96 0.64 72 150 100 260 200 40 1 2 
29 Amaidi 53/F 70 155 29.14 96 0.62 98 150 100 254 118 58.4 2 2 
30 Kesavan  32/M 57 153 24.35 77 0.50 96 180 110 177 135 35 1 2 
31 Dhanam 57.F 66 155 27.47 64 0.41 65 140 90 187 159 32 1 2 
32 Mary 65/F 58 144 27.97 98 0.68 70 150 100 215 88 52.8 2 2 
33 Pandiammal 51/F 56 162 21.34 88 0.54 90 150 90 221 226 41.6 2 2 
34 Gandhi 55/M 50 142 24.80 75 0.53 84 150 90 270 176 50.6 2 2 
35 Alagammal 45/F 73 153 31.18 90 0.59 90 140 80 147 100 42.3 2 2 
36 Pandiammal 43/F 75 162 28.58 95 0.59 89 150 100 255 213 35 2 2 
37 Ravichandran 50/M 64 164 23.80 86 0.52 99 170 100 232 187 31 1 2 
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38 Ganesan 40/M 49 163 18.44 60 0.37 100 140 90 190 110 41 2 2 
39 Sony 35/M 77 177 24.58 93 0.53 90 130 80 210 168 36 1 2 
40 Uma 52/F 66 143 32.28 92 0.64 90 130 80 240 110 35 1 2 
41 Suruliraj 59/M 65 152 28.13 104 0.68 88 140 100 210 140 36 1 2 
42 Jeyaram 55/M 70 156 28.76 86 0.55 79 150 80 180 145 40 1 2 
43 Sonai 56/M 50 160 19.53 81 0.51 92 130 70 170 110 40 1 2 
44 Chinnapan 57/M 45 160 17.58 81 0.51 138 140 90 220 200 35 1 2 
45 Mani 37/M 55 168 19.49 82 0.49 84 150 80 240 235 39 1 2 
46 Dharman 53/M 50 165 18.37 80 0.48 95 130 70 150 120 42 1 1 
47 Muthukrishnan 45/M 70 164 26.03 90 0.55 73 140 80 140 110 40 1 1 
48 Muthu 52/M 57 152 24.67 92 0.61 83 160 100 190 144 41 1 2 
49 Kalliappan 60/M 55 162 20.96 82 0.51 91 130 70 140 120 45 1 1 
50 Virumandi 62/M 60 162 22.86 88 0.54 150 150 70 220 95 39 1 2 
51 Dhanushkodi 47/M 62 174 20.48 88 0.51 140 140 100 170 120 40 1 2 
52 Chinnasamy 46/M 35 152 15.15 68 0.45 80 130 70 140 90 42 1 1 
53 Syed Moideen 49/M 45 150 20.00 66 0.44 93 120 80 120 95 40 1 1 
54 John 35/M 54 152 23.37 70 0.46 85 120 90 130 86 42 1 1 
55 Ramasamy 77/M 60 154 25.30 80 0.52 97 110 70 140 110 40 1 1 
56 Alagar 40/M 68 160 26.56 85 0.53 86 180 90 140 135 45 1 2 
57 Matchakalai 50/M 45 152 19.48 66 0.43 130 120 80 210 135 39 1 2 
58 Navaneethan 40/M 62 157 25.15 81 0.52 125 110 70 300 109 42 1 2 
59 Murugan 37/M 56 161 21.60 76 0.47 65 130 80 250 109 40 1 2 
60 Mayalagan 65/M 52 160 20.31 71 0.44 84 110 70 130 215 42 1 2 
61 Arumugan 25/M 47 157 19.07 60 0.38 78 130 80 181 220 41 1 2 
62 Kannan 42/M 56 163 21.08 75 0.46 85 140 80 168 134 42 1 1 
63 Sahul Hameed 46/M 67 173 22.39 90 0.52 179 140 90 168 290 42 2 2 
64 Kannadasamy 65/M 62 163 23.34 75 0.46 175 106 80 120 215 40 2 2 
65 Rajendran 38/M 66 158 26.44 84 0.53 125 130 80 122 144 42 1 2 
66 Ravichandran 42/M 58 162 22.10 78 0.48 69 110 80 139 158 44 1 2 
67 Alagar 41/M 89 164 33.09 110 0.67 78 120 80 258 210 35 1 2 
68 Sabarivasan 23/M 58 160 22.66 68 0.43 80 126 90 140 138 44 1 1 
69 Seenivasan 44/M 60 164 22.31 80 0.49 98 130 90 268 200 42 1 2 
70 Alagar 37/M 58 160 22.66 60 0.38 80 130 80 179 218 40 1 2 
71 Namasivayam 45/M 68 162 25.91 104 0.64 132 140 90 230 206 40 1 2 
72 Kamal 72/M 48 161 18.52 70 0.43 87 100 70 130 198 40 1 2 
73 Ayyavoo 65/M 69 153 29.48 88 0.58 91 130 80 201 207 42 1 2 
74 Baskaran 45/M 50 155 20.81 72 0.46 61 100 70 130 212 40 1 2 
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75 Gurunathan 60/M 68 167 24.38 84 0.50 94 130 80 198 129 40 1 1 
76 Paramasivam 56/M 55 163 20.70 79 0.48 186 100 70 161 116 42 1 2 
77 Kamarajan 26/M 52 162 19.81 72 0.44 95 110 70 145 211 40 1 2 
78 Thangamuniyandi 52/M 54 153 23.07 80 0.52 120 110 70 110 115 37 2 2 
79 Gothandaraman 64/M 58 165 21.30 78 0.47 69 140 90 129 201 46 2 2 
80 Kamatchi 65/M 52 152 22.51 71 0.47 60 130 70 122 203 44 1 2 
81 Ramanathan 43/M 60 162 22.86 70 0.43 88 100 70 128 98 42 1 1 
82 Arumugam  48/M 52 154 21.93 80 0.52 90 124 82 208 106 40 1 1 
83 Malayandi 80/M 49 161 18.90 61 0.38 84 110 90 124 104 45 1 1 
84 Muthupandiyan 55/M 60 164 22.31 86 0.52 88 100 70 240 190 36 1 2 
85 Sakthivel 52/M 48 158 19.23 63 0.40 68 110 80 182 108 41 2 2 
86 Sethumaran 65/M 56 168 19.84 66 0.39 84 140 80 188 220 38 1 2 
87 Jeyaraman 40/M 55 166 19.96 70 0.42 108 130 80 194 168 43 1 2 
88 Karuthakannan 55/M 55 170 19.03 78 0.46 120 110 70 182 206 43 1 2 
89 Subbaya 50/M 68 158 27.24 68 0.43 98 150 100 240 190 46 1 2 
90 Srinivasan 52/M 62 158 24.84 86 0.54 82 130 80 180 208 43 1 2 
91 Suthiya 52/M 70 165 25.71 89 0.54 118 140 90 146 198 43 1 2 
92 Duraisamy 80/M 61 158 24.44 68 0.43 81 130 70 160 185 32 1 2 
93 Mokkan 60/M 65 161 25.08 70 0.43 94 110 70 168 148 32 1 2 
94 Subramaniyan 65/M 75 169 26.26 78 0.46 137 100 70 110 217 35 2 2 
95 Kumarandi 50/M 65 162 24.77 70 0.43 120 120 80 196 240 32 1 2 
96 Balaguru 55/M 52 160 20.31 74 0.46 98 140 90 142 104 40 1 2 
97 Pandi 58/M 49 163 18.44 68 0.42 69 100 80 170 110 42 1 1 
98 Perumal Devar 41/M 51 158 20.43 69 0.44 143 170 100 123 100 43 1 2 
99 Karuppaiya 35/M 62 165 22.77 80 0.48 85 100 70 170 126 44 1 1 
100 Chandrasekar 32/M 51 165 18.73 68 0.41 63 110 80 130 124 42 1 1 
101 Balan 40/M 53 159 20.96 65 0.41 84 120 70 123 134 42 1 1 
102 Selvan  35/M 56 164 20.82 70 0.43 60 130 80 154 154 42 1 2 
103 Ganesan 60/M 59 162 22.48 82 0.51 61 110 70 120 173 50 1 2 
104 Kali 50/M 52 158 20.83 69 0.44 128 140 80 200 79 44 2 2 
105 Muthusamy 58/M 68 167 24.38 96 0.57 88 130 90 176 155 40 1 2 
106 Jeyakumar 45/M 55 167 19.72 70 0.42 108 180 80 140 168 38 1 2 
107 Karuppusamy 55/M 54 163 20.32 78 0.48 108 150 80 240 99 42 2 2 
108 Mari 54/M 48 162 18.29 68 0.42 69 100 80 130 80 40 1 1 
109 Senthil 35/M 80 166 29.03 101 0.61 91 110 70 183 247 29.4 1 2 
110 Pandi 48/M 63 160 24.61 97 0.61 89 110 80 120 125 23.2 1 2 
111 Irulandi 65/M 82 175 26.78 99 0.57 90 190 100 143 122 33.7 1 2 
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112 Velusamy 73/M 84 160 32.81 93 0.58 75 140 90 133 205 22.1 1 2 
113 Murugan 43/M 53 164 19.71 72 0.44 82 170 100 121 72 20.4 1 2 
114 Prakash 23/M 48 180 14.81 61 0.34 94 110 80 180 90 40 1 1 
115 Murugan 40/M 67 165 24.61 96 0.58 100 130 80 200 100 42 1 1 
116 Karunanidhi 58/M 45 168 15.94 156 0.93 104 130 80 71 189 48 1 2 
117 Mahamani 54/M 45 183 13.44 157 0.86 86 120 80 207 254 49 1 2 
118 Thanthi 60/M 40 159 15.82 157 0.99 130 100 70 100 142 25.2 2 2 
119 Muthiah  40/M 54 168 19.13 178 1.06 110 100 70 136 55 71.2 1 1 
120 Baskaran 38/M 65 185 18.99 160 0.86 140 110 80 300 160 30 2 2 
121 Mohan  36/M 66 175 21.55 181 1.03 86 110 70 144 76 29.1 1 2 
122 Manimegalai  45/F 75 102 72.09 162 1.59 95 130 80 90 180 40 1 2 
123 Prema 45/F 64 93 74.00 161 1.73 74 128 80 170 102 39 1 2 
124 Samuthiram 46/M 50 178 15.78 154 0.87 91 110 80 120 214 40 1 2 
125 Murugesan 55/M 68 104 62.87 162 1.56 132 140 90 130 198 40 2 2 
126 Sheik Masthu 65/M 43 160 16.80 70 0.44 104 160 100 169 60 40 2 2 
127 Anandham 60/M 47 164 17.47 66 0.40 68 150 70 104 74 42 2 2 
128 Karuppiah 52/M 53 162 20.20 77 0.48 103 180 70 112 98 30 2 2 
129 Sampath 45/M 53 170 18.34 76 0.45 112 150 110 254 173 35 2 2 
130 Chandramohan 32/M 74 180 22.84 90 0.50 67 150 90 240 421 39 1 2 
131 Raju 45M 51 168 18.07 74 0.44 356 110 70 157 145 36 2 2 
132 Ramuthai 36/F 27 148 12.33 48 0.32 195 110 70 201 105 38 1 2 
133 Murugavalli 35/F 30 142 14.88 66 0.46 96 110 70 278 117 40 1 2 
134 Ponnuthai 50/F 47 161 18.13 72 0.45 279 110 70 243 80 37 1 2 
135 Kaliyammal 34/F 39 148 17.80 81 0.55 120 170 110 231 97 35 1 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABBREVIATIONS AND 
ACRONYMS 
 
 
  
 
 
ABBREVIATIONS AND ACRONYMS 
 
• HTN – Hypertension 
• DM – Diabetes Mellitus 
• CVD – Cardiovascular Disease 
• BMI – Body Mass Index 
• LDL – Low Density Lipoprotein 
• HDL - High Density Lipoprotein 
• WC – Waist Circumference 
• TGL – Triglycerides 
• CAD – Coronary Artery Disease 
• TNF – Tumor Necrosis Factor 
 
 
